Thursday, April 17, 2014
Molecular analysis of lung tumors can help guide treatment decisions. Memorial Sloan Kettering is one of only a handful of centers nationwide to offer this personalized approach to care.
Every person who comes to Memorial Sloan Kettering for lung cancer treatment receives care from a multidisciplinary team of experts who focus exclusively on cancers of the chest and ensure you receive the combination of therapies that will give you the best chance of success.
Lung cancer is not just one disease but a complex collection of diverse types grouped into two categories: small cell lung cancer and non-small cell lung cancer. Each arises from different cells in the lung, grows and spreads in different ways, and requires different treatments.
Accurate diagnosis and staging are critical to an effective treatment plan. And because certain treatments are more effective than others against tumors with particular mutations, molecular analysis of individual tumors can help determine which therapy will be most beneficial. Memorial Sloan Kettering was among the first centers to apply this new approach to cancer treatment, and we are currently one of just a handful of hospitals in the world to offer this type of personalized medicine.
Our newly updated guide describes aspects of this tailored approach as well the breadth of our expertise: we offer a sophisticated lung cancer screening program and diagnose and treat more people with lung cancer than most other hospitals nationwide.
For example, our team of thoracic surgeons, among the most experienced in the US, performs more than 1,200 operations for lung cancer each year — and has one of the nation’s lowest post-operative complication rates. Whenever possible, we use minimally invasive procedures such as video-assisted thoracic surgery and robotic surgery.
Similarly, our medical oncologists use the most innovative drug approaches in treating people with both categories of lung cancer. These include targeted therapies and treatments that stimulate patients’ own immune systems to recognize and attack lung cancer. We also have the ability to deliver powerful doses of radiation directly to tumors with exquisite precision, minimizing the amount of radiation to surrounding healthy tissue and decreasing the risk of side effects.
Access to Cutting-Edge Treatments and Compassionate Care
By choosing Memorial Sloan Kettering, you may gain access to new treatments that are not widely available elsewhere, as well as additional options if your cancer has returned after standard therapy. You may wish to discuss clinical trial options with your doctor.
Knowing your level of lung cancer risk can help you and your doctor make decisions about your healthcare, including whether to get screened for lung cancer. Our experts have developed a risk assessment tool that considers various factors and predicts how likely you are to develop lung cancer.
Our unique Lung Cancer Survivorship Program provides follow-up care to monitor for signs of recurrence and help you and your loved ones address the physical, psychological, and emotional effects that can arise as a result of treatment.